$CDLX

CFO of Cardlytics (NASDAQ: CDLX) makes 200K-share open-market buy

Cardlytics (NASDAQ: CDLX) Chief Financial Officer David Thomas Evans recently purchased 200,000 shares of the company's common stock through open-market transactions. These purchases, totaling $129,000, occurred on May 15 and May 18, 2026, at weighted average prices of $0.649 and $0.633 per share, respectively. Following these transactions, Evans directly holds 317,930 shares of Cardlytics common stock.

Original reporting
Published May 20, 2026, 3:39 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 20, 2026, 4:01 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$CDLX
Bullish
medium confidence
Mentioned
$CDLX
alphai data visualization · based on Stock Titan
Decision brief

The 30-second read

$CDLXBullishMed
01

Why it matters

This activity may positively influence investor sentiment and could lead to increased buying interest in the stock.

02

Market read

The insider transaction is relevant for traders focusing on company-specific signals and insider sentiment indicators.

03

What to watch

Market conditions, upcoming earnings reports, or macroeconomic factors could overshadow insider activity's influence on stock performance.

Timing: High, as the purchase occurred recently and reflects current insider sentiment.

Background

The CFO's recent purchase of 200,000 shares indicates insider confidence, which is often viewed as a bullish indicator.

Company-level read

Ticker impact

$CDLXBullishMedium confidence
Context

This insider trading activity directly involves the company's stock, indicating potential insider confidence.

Expected impact

Moderate upward movement expected in the near term, contingent on broader market conditions.

Evidence & confidence

While insider buying is generally bullish, the relatively small purchase size compared to the company's market cap and the lack of additional positive catalysts limit the strength of this signal.

Market effects

Potential positive sentiment within the financial technology sector, possibly benefiting related stocks.

Limited regional impact, as the activity is specific to the company's stock in the US market.

Minimal, as this is a company-specific insider transaction.

Counterpoint

Insider buying could be motivated by personal reasons unrelated to the company's prospects; thus, it should not be solely relied upon for trading decisions.

Key entities

  • Cardlytics Inc.

    A marketing technology company specializing in purchase intelligence and marketing automation.

  • David Thomas Evans

    Chief Financial Officer of Cardlytics who made the recent share purchase.

Related articles

$CDLXMedAI 8/10

Cardlytics: Q2 Earnings Snapshot

Cardlytics (CDLX) reported a Q2 loss of $14.9 million, or $2.58 per share. Adjusted for discontinued operations, the loss was $1.50 per share. Revenue was $36.9 million. For the quarter ending September, the company expects revenue of $34 million to $39 million.

$CDLXMed

Cardlytics, Inc. (CDLX): Results of Operations and Financial Condition

Cardlytics, Inc. (CDLX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cdlx_form8-kx2026q2xex991.htm EX-99.1 Document Exhibit 99.1 Cardlytics Second Quarter 2026 Financial Results Driven By Strong Operational Performance • Company delivers strong second quarter results: ◦ Revenues of $36.9 million ◦ Billings of $65.5 million ◦ Adjusted Con

$ETNMed

Eaton Gains on $7-Million Contract

Eaton (NYSE:ETN) said the U.S. Air Force Research Laboratory awarded it a $7 million, 24-month contract to use quantum computing, machine learning, and advanced visualization to improve power grid resilience and protection. The work, with Infleqtion and Penn State, targets detection and response to multiple concurrent physical and cyber threats, addressing NERC N-2 contingency requirements.

$XOMMed

ExxonMobil awards McDermott engineering work for Rovuma LNG

ExxonMobil Moçambique Limitada issued McDermott Energy Solutions (UK) a letter of intent for limited engineering and procurement work on Rovuma LNG Phase 1 midstream development. The award supports planning ahead of a final investment decision expected in 2026. Rovuma LNG targets 12 modular trains totaling 18.6 mtpa, with start-up in 2031. ExxonMobil says the 30-year project could generate about $150B in revenues for Mozambique’s government.

$ESLTMed

Serbia to open joint UAV factory with Elbit in September

Serbia President Aleksandar Vucic said Serbia will open a joint UAV factory with Elbit Systems, with inauguration expected Sept 15-20. Elbit will hold 51% and Serbia’s state arms firm SDPR 49%. The factory relates to a five-year contract covering precision rockets and unmanned systems, plus ISTAR, digitization and upgrades.

$NOCMed

The Pentagon is urging defense contractors to urgently ramp up weapons production – WP

The U.S. Department of Defense, according to The Washington Post, asked defense contractors to submit within 21 days production and delivery schedules for critical systems, citing depleted stockpiles. CSIS estimates cite heavy early use of missiles and falling Patriot and THAAD inventories. The Pentagon is working with Northrop Grumman and Lockheed Martin, including a $58.6B deal to triple PAC-3 output by 2030, pending a stalled $1.15T defense budget.